SANGAMO THERAPEUTICS INC's ticker is SGMO and the CUSIP is 800677106. A total of 198 filers reported holding SANGAMO THERAPEUTICS INC in Q3 2022. The put-call ratio across all filers is 0.70 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $0 | -100.0% | 93 | 0.0% | 0.00% | – |
| Q1 2022 | $1,000 | 0.0% | 93 | 0.0% | 0.00% | – |
| Q4 2021 | $1,000 | -99.7% | 93 | -99.7% | 0.00% | -100.0% |
| Q3 2021 | $329,000 | -30.0% | 36,537 | -6.9% | 0.01% | -33.3% |
| Q2 2021 | $470,000 | -7.8% | 39,250 | -3.5% | 0.02% | -19.2% |
| Q1 2021 | $510,000 | -33.3% | 40,694 | -17.0% | 0.03% | -38.1% |
| Q4 2020 | $765,000 | +252.5% | 49,039 | +113.7% | 0.04% | +200.0% |
| Q3 2020 | $217,000 | +6.9% | 22,951 | +1.2% | 0.01% | -6.7% |
| Q2 2020 | $203,000 | +55.0% | 22,668 | +10.6% | 0.02% | +36.4% |
| Q1 2020 | $131,000 | -30.3% | 20,490 | -8.8% | 0.01% | -15.4% |
| Q4 2019 | $188,000 | – | 22,474 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| FIC CAPITAL INC | 875,284 | $2,670,000 | 1.34% |
| NEXTHERA CAPITAL LP | 503,000 | $1,534,000 | 0.90% |
| Opaleye Management Inc. | 400,000 | $1,220,000 | 0.72% |
| WASATCH ADVISORS LP | 7,256,260 | $22,132,000 | 0.33% |
| Cormorant Asset Management, LP | 650,000 | $1,983,000 | 0.27% |
| Sicart Associates LLC | 101,950 | $311,000 | 0.22% |
| Baker Brothers Advisors | 4,055,876 | $12,370,000 | 0.12% |
| Leisure Capital Management | 43,008 | $131,000 | 0.12% |
| Piermont Capital Management Inc. | 165,569 | $505,000 | 0.12% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 837,963 | $2,556,000 | 0.10% |